The shares of Emergent Biosolutions Inc (EBS) have recorded the market capitalization of 203.84M
The stock of Emergent Biosolutions Inc (NYSE:EBS) last traded at $3.89, up 17.88% from the previous session. EBS stock price is now 58.10% away from the 50-day moving average and 28.20% away from the 200-day moving average. The market capitalization of the company currently stands at $203.84M. With the price target maintained at $5, The […]
A Stock With Stellar Fundamentals? Emergent BioSolutions Inc. (NYSE:EBS): Is It Right For You?
Stocks of Emergent BioSolutions Inc. (NYSE:EBS) traded higher last session on Wall Street, down -4.11% to $3.97. According to the data, Emergent BioSolutions Inc. (NYSE:EBS) has 3 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $22.00 and […]
Do you still think Emergent BioSolutions Inc. (NYSE:EBS) is worth a look?
In yesterday’s Wall Street session, Emergent BioSolutions Inc. (NYSE:EBS) shares traded at $4.54, up 11.55% from the previous session. As of this writing, 3 analysts cover Emergent BioSolutions Inc. (NYSE:EBS). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $22.00 and a […]
A Stock With Stellar Fundamentals? Emergent BioSolutions Inc. (NYSE:EBS): Is It Right For You?
Stocks of Emergent BioSolutions Inc. (NYSE:EBS) traded higher last session on Wall Street, up 1.12% to $4.53. According to the data, Emergent BioSolutions Inc. (NYSE:EBS) has 3 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $22.00 and […]
How should investors evaluate Emergent BioSolutions Inc. (NYSE:EBS)?
Stocks of Emergent BioSolutions Inc. (NYSE:EBS) traded higher last session on Wall Street, down -4.37% to $7.01. According to the data, Emergent BioSolutions Inc. (NYSE:EBS) has 3 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $22.00 and […]
